The delay in the diagnosis and treatment of newly diagnosed bladder cancer patients during COVID 19 pandemic

dc.authoridYazıcı, Cenk Murat/0000-0001-6140-5181
dc.authorwosidYazıcı, Cenk Murat/AAA-4330-2020
dc.contributor.authorDoğan, Çağrı
dc.contributor.authorYazıcı, Cenk Murat
dc.contributor.authorAkgül, Hacı Murat
dc.contributor.authorÇınar, Önder
dc.contributor.authorAteş, Hüseyin
dc.contributor.authorYaz, İlyas
dc.date.accessioned2023-05-06T17:22:12Z
dc.date.available2023-05-06T17:22:12Z
dc.date.issued2022
dc.departmentFakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Üroloji Ana Bilim Dalı
dc.description.abstractBackground: To evaluate the newly diagnosed bladder cancer(BC) patients during the pandemic period and compare them with the corresponding last4 years. Objectives: To document the time schedules of BC patient evaluation and define the possible delays and investigate the reasons. Methods: Newly diagnosed BC patients who underwent transurethral resection of bladder tumour in the last5 years were retrospectively included to study.The patients were divided into 5 groups.Group-1 was composed of patients diagnosed be-tweenMarch,1,2016-March-1,2017. The patients who were diagnosed in the further corresponding years formed group 2,3 and 4. The last group(Group-5) was composed of patients who were diagnosed during the pandemic period which was between March,1,2020 and March,1,2021. The clinicodemographic properties and diagnostic time schedules of the patients were com-pared between the groups. Results: There were56 patients in Group-1,60 patients in Group-2,61 patients in Group-3,68 patients in Group-4,and58 pa-tients inGroup-5. The mean hospital admission period was102.5 +/- 179.0days during the pandemic period which ranged be-tween24.5 +/- 32.0 and38.3 +/- 69.1days before thepandemic.(p=0.002)The diagnosis-anesthesia period was significantly higher during the pandemic pandemic period.(p=0.034) Conclusions: The pandemic period has caused some delays in the diagnosis and treatment of BC patients. Telemonitoring systems may be useful to prevent the possible diagnostic and treatment delays for newly diagnosed BC patients.
dc.identifier.doi10.4314/ahs.v22i3.26
dc.identifier.endpage249
dc.identifier.issn1680-6905
dc.identifier.issn1729-0503
dc.identifier.issue3en_US
dc.identifier.pmid36910348
dc.identifier.scopus2-s2.0-85140852557
dc.identifier.scopusqualityQ3
dc.identifier.startpage241
dc.identifier.urihttps://doi.org/10.4314/ahs.v22i3.26
dc.identifier.urihttps://hdl.handle.net/20.500.11776/12107
dc.identifier.volume22
dc.identifier.wosWOS:000879671000026
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorDoğan, Çağrı
dc.institutionauthorYazıcı, Cenk Murat
dc.institutionauthorAkgül, Hacı Murat
dc.institutionauthorAteş, Hüseyin
dc.language.isoen
dc.publisherMakerere Univ, Coll Health Sciences,Sch Med
dc.relation.ispartofAfrican Health Sciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCOVID-19
dc.subjectbladder cancer
dc.subjectpandemic
dc.subjecttreatment
dc.subjectCystectomy
dc.subjectSurvival
dc.titleThe delay in the diagnosis and treatment of newly diagnosed bladder cancer patients during COVID 19 pandemic
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
12107.pdf
Boyut:
450.71 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text